Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Steve Attanasio , Raed Al Dallow , Sandeep Nathan Added: 3 years ago
While acute coronary syndromes inclusive of ST-elevation myocardial infarction (STEMI) have been described in patients with polycythemia vera (PCV), optimal pharmacologic and interventional management strategies in the setting of drastically elevated platelet counts remain unclear.1 To our knowledge this is the first reported case of STEMI with massive thrombus burden in a patient with PCV… View more
Author(s): Geoffrey Houlton Added: 3 years ago
Cardiovascular (heart) disease is the cause of more deaths in the western world than all other forms of disease. In the coming years this problem is predicted to escalate as the majority of the ‘baby boomer’ generation will be well into retirement. As a result, technologies that improve the assessment of or aid in the detection of heart disease will become increasingly important in patient… View more
Author(s): Robert F Riley , James M McCabe Added: 3 years ago
Heart disease remains the leading cause of death in the US, with ischemic heart disease comprising almost half of these deaths based on the most recent 2013 mortality data.1 While there have been reports of declining rates of acute myocardial infarction (AMI) from various registries and Medicare beneficiary reports, coronary heart disease remained the underlying cause of death in one out of seven… View more
Author(s): Derek P Chew , Harvey D White Added: 3 years ago
The cumulative evidence base informing almost every aspect of myocardial infarction acute coronary syndrome (ACS) care is expansive and has been associated with a decline in the rate of mortality. Within the context of current-era clinical trials of ST-segment-elevation myocardial infarction, 30-day mortality rates of 4–5% have now been reported for high-risk individuals,1,2 with similar rates… View more
Author(s): Joris van den Hurk Added: 3 years ago
Cardiovascular disease (CVD) is the most common cause of death worldwide.1 With an estimated 7.6 million global deaths due to coronary heart disease in 2005,2 the size of the burden placed on society cannot be understated. Acute myocardial infarction (AMI), the classic ‘heart attack,’ will be the classification given to many of these deaths. In its most life-threatening form, AMI is identified… View more
Author(s): Sandeep Nathan , Rajiv Swamy Added: 3 years ago
The spectrum of acute coronary syndromes (ACS) encompasses a broad array of clinical characteristics and risk strata, ranging from unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) to ST-segment elevation myocardial infarction (STEMI) and sudden cardiac death (SCD). In this article, UA and NSTEMI will be considered together as non-ST-segment elevation acute coronary… View more
Author(s): Hillel A Steiner , Yonathan Hasin Added: 3 years ago
Sudden cardiac death (SCD) remains a public health problem of immense magnitude, afflicting an estimated 300,000 persons per year in the US.1 SCD, defined as death occurring within one hour from symptom-onset, is associated with ischemic heart disease in 80% of cases. Approximately one-third of cases are the result of an acute occlusion of an epicardial coronary artery.2 Some 50% of the mortality… View more
Author(s): Elliott M Antman Added: 3 years ago
In July 2004, the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Task Force on Practice Guidelines released new practice guidelines for ST-elevation myocardial infarction (STEMI), which emphasize the need for speed when chest pain or other symptoms of a heart attack strike. Speedy treatment not only means the difference between life and death but also between… View more
Author(s): Elliott M Antman Added: 3 years ago
In July 2004, the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Task Force on Practice Guidelines released new practice guidelines for ST-elevation myocardial infarction (STEMI), which emphasize the need for speed when chest pain or other symptoms of a heart attack strike. Speedy treatment not only means the difference between life and death but also between… View more
Author(s): Giovanni Luigi Di Maria Added: 5 months ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more